Rody San Martín Selected Research

Proteinuria

1/2017	Deficient Insulin-mediated Upregulation of the Equilibrative Nucleoside Transporter 2 Contributes to Chronically Increased Adenosine in Diabetic Glomerulopathy.
1/2013	Adenosine A(2B) receptor-mediated VEGF induction promotes diabetic glomerulopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rody San Martín Research Topics

Disease

10	Glioblastoma (Glioblastoma Multiforme) 08/2022 - 04/2011
9	Diabetic Nephropathies (Diabetic Nephropathy) 01/2024 - 10/2009
6	Neoplasms (Cancer) 04/2023 - 04/2011
6	Hypoxia (Hypoxemia) 04/2023 - 07/2005
5	Fibrosis (Cirrhosis) 11/2020 - 01/2016
4	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2006 - 10/2004
2	Proteinuria 01/2017 - 01/2013
2	Glioma (Gliomas) 10/2016 - 03/2013
2	Hyperglycemia 03/2012 - 12/2006
1	Inflammation (Inflammations) 11/2020
1	Chronic Renal Insufficiency 01/2017
1	Ischemia 01/2017
1	Breast Neoplasms (Breast Cancer) 03/2013
1	Hyperinsulinism (Hyperinsulinemia) 03/2012
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 07/2005
1	Diabetes Mellitus 10/2004

Drug/Important Bio-Agent (IBA)

21	Adenosine (Adenocard)FDA LinkGeneric 01/2024 - 10/2004
6	Purinergic P1 Receptors (Adenosine Receptor)IBA 08/2022 - 10/2009
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2018 - 10/2009
3	Equilibrative Nucleoside Transporter 1IBA 01/2020 - 10/2004
3	multidrug resistance-associated protein 1IBA 10/2016 - 04/2011
3	Proteins (Proteins, Gene)FDA Link 08/2011 - 10/2004
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2009 - 10/2004
2	NucleosidesIBA 01/2024 - 07/2005
2	Insulin (Novolin)FDA Link 01/2024 - 03/2012
2	5'-Nucleotidase (5' Nucleotidase)IBA 01/2020 - 03/2013
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 08/2006 - 07/2005
2	4-nitrobenzylthioinosineIBA 07/2005 - 10/2004
2	Messenger RNA (mRNA)IBA 07/2005 - 10/2004
2	Nitric Oxide Synthase (NO Synthase)IBA 07/2005 - 10/2004
1	Teniposide (VM 26)FDA Link 08/2022
1	N- (4- cyanophenyl)- 2- (4- (2,3,6,7- tetrahydro- 2,6- dioxo- 1,3- dipropyl- 1H- purin- 8- yl)- phenoxy)acetamideIBA 01/2020
1	prostatic acid phosphataseIBA 01/2019
1	nephrinIBA 01/2017
1	Adenosine DeaminaseIBA 01/2017
1	ReninIBA 01/2017
1	SodiumIBA 01/2017
1	Adenosine A3 ReceptorIBA 10/2016
1	beta-thujone (thujone)IBA 01/2016
1	Adenosine Monophosphate (AMP)IBA 03/2013
1	EnzymesIBA 03/2013
1	Streptozocin (Streptozotocin)FDA Link 03/2012
1	Glucose (Dextrose)FDA LinkGeneric 03/2012
1	FructoseIBA 03/2012
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 04/2011
1	S-Nitroso-N-AcetylpenicillamineIBA 08/2006
1	Penicillamine (Cuprimine)FDA Link 08/2006
1	adenosine transporterIBA 08/2006
1	LigandsIBA 07/2005
1	Oxygen (Dioxygen)IBA 07/2005
1	MAP Kinase Kinase 1IBA 07/2005
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 07/2005
1	CitrullineIBA 10/2004
1	Purinergic Receptors (Receptors, Purine)IBA 10/2004
1	Cationic Amino Acid Transporter 1IBA 10/2004
1	ZM 241385 (ZM241385)IBA 10/2004
1	MitogensIBA 10/2004
1	Protein Kinases (Protein Kinase)IBA 10/2004
1	Phosphotransferases (Kinase)IBA 10/2004
1	Arginine (L-Arginine)FDA Link 10/2004

Therapy/Procedure

2	Therapeutics 04/2023 - 04/2011
1	Homeopathy 01/2016
1	Renal Dialysis (Hemodialysis) 04/2013
1	Drug Therapy (Chemotherapy) 04/2011